This is a medicine used to help open up the airways in your lungs, often for conditions like COPD or asthma. It's usually given as a spray or inhaler to help you breathe easier.
Every report comes from a Lived member, sent anonymously.
Have you tried Atrovent (Ipratropium) for COPD?
Ipratropium is a prescription medicine that comes in two very different forms: an inhaled medicine for the lungs and a nasal spray for the nose. The inhaled form, sold as the Atrovent HFA inhaler (HFA stands for hydrofluoroalkane, the propellant that pushes out each puff) and as a generic solution for nebulizers, is approved as a maintenance treatment for chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is taken regularly to keep the airways more open and ease wheezing, coughing and shortness of breath. It is not a rescue inhaler for a sudden breathing attack. The nasal spray, available as generic ipratropium in two strengths, treats a runny nose. The 0.03% spray is for year-round allergic and nonallergic rhinitis in people 6 and older. The 0.06% spray is for a runny nose from a cold (people 5 and older, studied for up to four days) or from seasonal allergies (studied for up to three weeks). It dries a dripping nose but does not relieve a stuffy nose, sneezing or postnasal drip. Ipratropium is also combined with albuterol in products such as Combivent Respimat for people with COPD who need a second bronchodilator. In emergency care, doctors may add nebulized ipratropium to albuterol for a severe asthma attack, but asthma is not an approved use of ipratropium on its own.
Acetylcholine is a chemical messenger that nerves release to tighten the muscle around the airways and to stimulate mucus glands. Ipratropium is an anticholinergic: it blocks the receptors acetylcholine acts on. In the lungs, this lets the airway muscle relax, so the airways widen and air moves in and out more easily. In the nose, the same blocking effect reduces the watery mucus that causes a runny nose, which is why it helps dripping but not congestion. Because very little of an inhaled or sprayed dose is absorbed into the bloodstream, its effects stay mostly where it is applied. In COPD, a dose starts working within about 15 minutes, peaks in one to two hours and lasts two to four hours. That relatively short action is why it is taken several times a day.
The Atrovent HFA inhaler is usually used as two puffs four times a day. Extra puffs may be taken if the prescriber allows, but the total should not exceed 12 puffs in 24 hours. Unlike many inhalers, it does not need shaking. Spray two test puffs into the air, away from the face, before the first use and again if it has not been used for more than three days. Throw it away after the labeled number of puffs, even if it still feels like something is inside. The nebulizer solution comes in single-dose vials, usually used three or four times a day, six to eight hours apart. It can be mixed with albuterol in the nebulizer if used within an hour. A mouthpiece may be better than a face mask because it keeps the mist away from the eyes. The nasal sprays are used as two sprays in each nostril two to four times a day, depending on the strength and the reason for use. The pump needs priming before first use and after it has sat unused. Whatever the form, avoid spraying it into or near the eyes.
Inhaled ipratropium is usually well tolerated. Dry mouth, a bitter taste, headache, nausea and dizziness are among the more common complaints. With the nasal spray, nasal dryness and nosebleeds are the most frequent problems; they are usually mild and often settle on their own or with a lower dose. Tell the prescriber if dryness or nosebleeds keep happening. Because dizziness and blurred vision can occur, take care with driving until you know how it affects you. Rarely, an inhaled dose makes breathing worse right after using it, with sudden wheezing or chest tightness. This is called paradoxical bronchospasm and can be serious: stop using ipratropium and get urgent medical help. Allergic reactions are also rare. Hives or a rash mean stopping the medicine and contacting the prescriber; swelling of the face, lips, tongue or throat, or trouble breathing or swallowing, is an emergency that needs a 911 call.
Do not use ipratropium if you are allergic to it or to atropine or related medicines. Using it alongside other anticholinergic drugs can add up the same side effects. These include other inhaled COPD medicines of the same type, such as tiotropium (Spiriva), as well as some bladder, stomach and older allergy medicines. Ask a pharmacist to check your list. Anticholinergic medicines can raise pressure inside the eye, which can trigger or worsen narrow-angle glaucoma (a type of glaucoma in which the eye's drainage angle can suddenly close). People with this condition need extra caution, and anyone using ipratropium should keep it out of the eyes. Eye pain, blurred vision, seeing halos or colored rings around lights, or red eyes during treatment should be reported to the care team right away. Ipratropium can also make it harder to pass urine, especially in men with an enlarged prostate or anyone with a bladder blockage. Tell the prescriber if urinating becomes difficult. In pregnancy, so little inhaled ipratropium reaches the bloodstream that the baby is not expected to be exposed, and decades of published experience have not shown a link to birth defects or miscarriage.
With the inhaler or nebulizer, breathing often eases within about 15 minutes of a dose, but ipratropium works best when used regularly as prescribed rather than only when symptoms flare. Keep a separate quick-relief inhaler, usually albuterol, for sudden breathlessness. Ipratropium is an older, short-acting option. For stable COPD, guidelines generally prefer once-daily long-acting medicines such as tiotropium, which in studies led to fewer flare-ups and hospital stays than ipratropium. Some people still use ipratropium because of cost, a nebulizer routine, or as part of a combination product, and a prescriber may suggest a switch at a check-up. If ipratropium seems to work less well, your symptoms get worse, or you find yourself needing it more often than usual, contact your care team right away, since this can signal a COPD flare-up that needs a change in treatment. The nasal spray can reduce a runny nose within the first days of use. For a cold, it is meant for short-term use only.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Atrovent (Ipratropium), what you've noticed, or ask the community a question.